SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT
NEOT 1.919+4.3%Jan 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marty who wrote (64)12/13/1999 11:04:00 PM
From: tuck  Read Replies (1) of 204
 
Marty,

You may have already seen these, but here's a couple more links to the competition's programs. You seem to be correct in that NEOT appears to be ahead in the race, except for the mysterious Cerebrolysin from the mysterious Ebewe. I'm getting mighty tempted to bite at NEOT.

mabxa.com

allelix.com

NEOT does seem as if the they will be first to market unless Cerebrolysin's PIII trials are successful and the product is a hit. Then maybe we'd hear about it. What's up with that and the Street's ignorance/undervaluation of NEOT? Something wrong with its perception or ours? I still don't know.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext